These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10468077)

  • 1. Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution.
    Feldman M; Cryer B
    Am J Cardiol; 1999 Aug; 84(4):404-9. PubMed ID: 10468077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations.
    Schwertner HA; McGlasson D; Christopher M; Bush AC
    Thromb Res; 2006; 118(4):529-34. PubMed ID: 16298420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, quadruple crossover single-blind study on immediate action of chewed and unchewed low-dose acetylsalicylic acid tablets in healthy volunteers.
    Sai Y; Kusaka A; Imanishi K; Matsumoto M; Takahashi R; Sugimoto N; Sugama J; Anada T; Asakura H; Miyamoto K
    J Pharm Sci; 2011 Sep; 100(9):3884-91. PubMed ID: 21544823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining platelet response to acetylsalicylic acid: the relation between inhibition of serum thromboxane B
    Gurbel PA; Bliden KP; Tantry US
    J Thromb Thrombolysis; 2021 Feb; 51(2):260-264. PubMed ID: 33170486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers.
    Cox D; Maree AO; Dooley M; Conroy R; Byrne MF; Fitzgerald DJ
    Stroke; 2006 Aug; 37(8):2153-8. PubMed ID: 16794200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes.
    Cerletti C; Dell'Elba G; Manarini S; Pecce R; Di Castelnuovo A; Scorpiglione N; Feliziani V; de Gaetano G
    Clin Pharmacokinet; 2003; 42(12):1059-70. PubMed ID: 12959636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, open-label, crossover trial comparing the pharmacokinetic profile of a novel oral aspirin solution and a chewed aspirin tablet.
    Atar D; Sarkar S; Kolev E; Mura C; Brosstad F; Theodorsen L; Westen GI; Stribolt-Halvorsen PE
    Int J Clin Pharmacol Ther; 2022 Oct; 60(10):430-438. PubMed ID: 35979901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus.
    Bhatt DL; Grosser T; Dong JF; Logan D; Jeske W; Angiolillo DJ; Frelinger AL; Lei L; Liang J; Moore JE; Cryer B; Marathi U
    J Am Coll Cardiol; 2017 Feb; 69(6):603-612. PubMed ID: 28089180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation.
    Patrick J; Dillaha L; Armas D; Sessa WC
    Postgrad Med; 2015 Aug; 127(6):573-80. PubMed ID: 25998572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics and pharmacokinetics of a novel, low-dose, soft-gel capsule of acetylsalicylic acid in comparison with an oral solution after single-dose administration to healthy volunteers: a phase I, two-way crossover study.
    Loprete L; Leuratti C; Scarsi C; Radicioni M
    Clin Drug Investig; 2014 Jan; 34(1):19-25. PubMed ID: 24132773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticlopidine, Alka-Seltzer, or a combination of citric acid with aspirin: effects on platelet aggregation in individuals with an insufficient response to aspirin alone.
    Kaplan S; Kaplan A; Marcoe K; Sauvage LR
    Clin Appl Thromb Hemost; 2000 Oct; 6(4):222-5. PubMed ID: 11030528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in thromboxane B2 concentrations in serum and plasma in patients taking regular aspirin before and after clopidogrel therapy.
    Good RI; McGarrity A; Sheehan R; James TE; Miller H; Stephens J; Watkins S; McConnachie A; Goodall AH; Oldroyd KG
    Platelets; 2015; 26(1):17-24. PubMed ID: 24433337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylsalicylic acid in critically ill patients: a cross-sectional and a randomized trial.
    Schoergenhofer C; Hobl EL; Schwameis M; Gelbenegger G; Staudinger T; Heinz G; Speidl WS; Zauner C; Reiter B; Lang I; Jilma B
    Eur J Clin Invest; 2017 Jul; 47(7):504-512. PubMed ID: 28556061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of oral aspirin versus topical applied methyl salicylate for platelet inhibition.
    Tanen DA; Danish DC; Reardon JM; Chisholm CB; Matteucci MJ; Riffenburgh RH
    Ann Pharmacother; 2008 Oct; 42(10):1396-401. PubMed ID: 18698012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First In-Human Experience With Inhaled Acetylsalicylic Acid for Immediate Platelet Inhibition: Comparison With Chewed and Swallowed Acetylsalicylic Acid.
    Gurbel PA; Bliden KP; Chaudhary R; Tantry US
    Circulation; 2020 Sep; 142(13):1305-1307. PubMed ID: 32986482
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study.
    Franchi F; Schneider DJ; Prats J; Fan W; Rollini F; Been L; Taatjes-Sommer HS; Bhatt DL; Deliargyris EN; Angiolillo DJ
    J Thromb Thrombolysis; 2022 Oct; 54(3):373-381. PubMed ID: 36036856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Chewing vs Swallowing Ticagrelor on Platelet Inhibition in Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial.
    Asher E; Tal S; Mazin I; Abu-Much A; Sabbag A; Katz M; Regev E; Chernomordik F; Guetta V; Segev A; Elian D; Barbash I; Fefer P; Narodistky M; Beigel R; Matetzky S
    JAMA Cardiol; 2017 Dec; 2(12):1380-1384. PubMed ID: 29071332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel.
    Gurbel PA; Bliden KP; Fort JG; Jeong YH; Shuldiner A; Chai S; Gesheff T; Antonino M; Gesheff M; Zhang Y; Tantry US
    Am Heart J; 2013 Feb; 165(2):176-82. PubMed ID: 23351820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment.
    Temperilli F; Rina A; Massimi I; Montemari AL; Guarino ML; Zicari A; Pulcinelli FM
    Platelets; 2015; 26(8):783-7. PubMed ID: 25734355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.